What is the 13F Pro Quality Score for THC?

13F Pro ranks TENET HEALTHCARE CORP (THC) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View THC's current score at https://13fpro.ai/company/THC (free sign-up required for the full ranking).

Which hedge funds own the most THC stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of THC include BlackRock,, PRICE T ROWE ASSOCIATES /MD/, Boston Partners. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/THC as soon as new 13F filings post.

Where does 13F Pro source THC data?

All TENET HEALTHCARE CORP fundamentals and ownership data come directly from SEC EDGAR. TENET HEALTHCARE CORP files with the SEC under CIK 70318. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is THC in?

TENET HEALTHCARE CORP (THC) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives THC's revenue?

Per TENET HEALTHCARE CORP's latest 10-Q filed with the SEC on 2026-07-29, the biggest revenue drivers are: Hospital Operations ($4,240M, +6.0% YoY); Ambulatory Care ($1,388M, +9.3% YoY); Managed care ($2,470M, +1.9% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/THC.

What are THC's largest expenses?

TENET HEALTHCARE CORP's latest 10-Q reports these as the largest expense items: Salaries, wages and benefits ($2,231M, +3.3% YoY); Supplies ($984M, +5.6% YoY); Other operating expenses, net ($1,174M, +4.9% YoY). Sourced directly from SEC EDGAR filing text for Q2 FY2026 (quarter ended June 30, 2026).

How often is THC research updated on 13F Pro?

THC's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

TENET HEALTHCARE CORP(THC)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSElarge

Institutional-grade research for retail investors

SEC EDGAR: CIK 70318 THC stock profile & AI dashboard →

13F Pro Quality Score

66.2/100

Rank #435 of 2,961 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

33.7/100

Profitability

74.6/100

Balance Sheet

85.0/100

Earnings Quality

71.4/100

Free Cash Flow

63.5/100

Institutional Flow

74.9/100

Revenue Scale

93.2/100

Dilution Risk

75.8/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why THC Scores 66/100

exact factor attribution · 2026-09-11

THC's composite is driven by scale and profitability, held back by revenue growth. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Scale

+6.5 pts

93th pct

Profitability

+3.7 pts

75th pct

Capital efficiency

+3.5 pts

85th pct

Earnings quality

+2.1 pts

71th pct

Free cash flow

+2.0 pts

64th pct

Shareholder dilution

+1.3 pts

76th pct

Institutional flow

+1.3 pts

75th pct

Earnings growth

-0.9 pts

33th pct

Revenue growth

-3.3 pts

34th pct

Latest change (2026-07-31): 67 → 73 · ↑ Profit margin 61→81; ↑ Earnings growth 28→77

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

THC Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for TENET HEALTHCARE CORP (THC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores THC at 66.2/100 on a 32-signal composite quality model, placing it at rank #435 of 2,961 stocks — the top 25% of the AI-ranked universe. THC scores in the top quartile across revenue scale (93.2), balance sheet strength (85.0). Areas of concern include revenue growth (33.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), TENET HEALTHCARE CORP reports quarterly revenue of $5.6B, net income of $1.0B, free cash flow of $417.0M. Top institutional holders of THC by reported 13-F value include BlackRock, PRICE T ROWE ASSOCIATES, Boston Partners, based on the most recent SEC filings. THC trades on the NYSE exchange and files with the SEC under CIK 70318. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate THC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TENET HEALTHCARE CORP directly from SEC EDGAR. TENET HEALTHCARE CORP's 13F Pro composite quality score has ranged between 52 and 78 since 2021, currently 66.2 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.

What's Driving THC's Business? Latest 10-Q Breakdown

✓ 15/15 datapoints verified

AI-extracted from TENET HEALTHCARE CORP's 10-Q filed 2026-07-29 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Tenet's Q2 revenue rose 6.8% YoY to $5.628B, but operating income nearly doubled to $1.501B largely because of a one-time $413M contract-termination payment from the CHI/Conifer settlement.

Biggest Revenue Drivers

Hospital Operations$4,240M+6.0% YoY

Higher patient volumes, partially offset by a less favorable payer mix

Ambulatory Care$1,388M+9.3% YoY

Driven by 2025/2026 acquisitions, de novo development and same-facility commercial rate increases

Biggest Revenue Drivers

Total revenue: $5.628B+6.8% YoY

Hospital Operations$4,240M+6.0% YoY

Higher patient volumes, partially offset by a less favorable payer mix

Within Hospital Operations

Managed care$2,470M+1.9% YoY

Includes Medicare and Medicaid managed care programs

Medicaid$505M+33% YoY

Growth tied to DSH and other supplemental program revenue

Ambulatory Care$1,388M+9.3% YoY

Driven by 2025/2026 acquisitions, de novo development and same-facility commercial rate increases

Largest Expense Items

Salaries, wages and benefits$2,231M+3.3% YoY

Annual merit increases and higher incentive compensation, partly offset by lower health benefits cost

Supplies$984M+5.6% YoY

Higher patient volumes, partially offset by cost-efficiency measures

Other operating expenses, net$1,174M+4.9% YoY

Increases in malpractice expense and medical fees

Margins: Operating margin expanded to 26.7% from 15.6% a year ago, but the filing attributes 7.3 percentage points of revenue to the one-time contract-termination payment, meaning underlying margin improvement is smaller than the headline suggests.

Watch Items from the Filing

$413M of Q2 revenue came from a one-time contract-termination payment tied to the CHI/Conifer Omnibus Agreement, not recurring operations.
Managed care fell to 67.3% of net patient service revenue from 70.2% while Medicaid rose to 13.8% from 11.0%, a less favorable payer mix shift.
OBBBA Medicaid provisions taking effect mostly in 2027 (work requirements, provider tax limits, state-directed payment caps) could materially reduce future Medicaid payments; Tenet cannot yet estimate the impact.
Repurchased 5.675 million shares for $1.042 billion in the quarter, with $2.130 billion still authorized after a $2.0 billion increase in June 2026.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$5.6B

Net Income

Q2 2026

$1.0B

Free Cash Flow

Q2 2026

$417.0M

ROIC

Q2 2026

33.5%

D/E Ratio

Q2 2026

2.84

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+3.1% YoY

$21.31BFY 2025

FY22 $19.17BFY23 $20.56BFY24 $20.68BFY25 $21.31B

Net Income

-41.8% YoY

$2.37BFY 2025

FY22 $1.00BFY23 $1.31BFY24 $4.06BFY25 $2.37B

Operating Income

-41.1% YoY

$3.51BFY 2025

FY22 $2.33BFY23 $2.51BFY24 $5.96BFY25 $3.51B

EPS (Diluted)

-52.6% YoY

$15.49FY 2025

FY22 $3.79FY23 $5.71FY24 $32.70FY25 $15.49

Total Assets

+2.6% YoY

$29.68BFY 2025

FY22 $27.16BFY23 $28.31BFY24 $28.94BFY25 $29.68B

Total Debt

-0.0% YoY

$13.17BFY 2025

FY22 $15.08BFY23 $15.00BFY24 $13.17BFY25 $13.17B

Op. Cash Flow

+72.9% YoY

$3.54BFY 2025

FY22 $1.08BFY23 $2.37BFY24 $2.05BFY25 $3.54B

Free Cash Flow

+126.7% YoY

$2.53BFY 2025

FY22 $321.0MFY23 $1.62BFY24 $1.12BFY25 $2.53B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$21.31B +3.1%	$20.68B +0.5%	$20.56B +7.2%	$19.17B -1.6%	$19.48B +10.5%	$17.64B
Net Income	$2.37B -41.8%	$4.06B +210.0%	$1.31B +31.0%	$1.00B -32.2%	$1.48B	—
Operating Income	$3.51B -41.1%	$5.96B +137.3%	$2.51B +7.6%	$2.33B -18.7%	$2.87B +44.3%	$1.99B
EPS (Diluted)	$15.49 -52.6%	$32.70 +472.7%	$5.71 +50.7%	$3.79 -55.0%	$8.42 +124.5%	$3.75
Total Assets	$29.68B +2.6%	$28.94B +2.2%	$28.31B +4.3%	$27.16B -1.5%	$27.58B +1.7%	$27.11B
Total Debt	$13.17B -0.0%	$13.17B -12.2%	$15.00B -0.5%	$15.08B -3.6%	$15.65B -0.5%	$15.72B
Operating Cash Flow	$3.54B +72.9%	$2.05B -13.8%	$2.37B +119.2%	$1.08B -30.9%	$1.57B -54.0%	$3.41B
Free Cash Flow	$2.53B +126.7%	$1.12B -31.2%	$1.62B +405.6%	$321.0M -64.7%	$910.0M -68.3%	$2.87B

Get alerted when THC's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for TENET HEALTHCARE CORP including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of THC

BlackRock, Inc.
$1.6B8,743,005 sh
PRICE T ROWE ASSOCIATES INC /MD/
$1.5B7,957,449 sh
Boston Partners
$829.1M4,433,360 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$792.9M4,238,108 sh
FMR LLC
$747.3M3,994,545 sh
VANGUARD CAPITAL MANAGEMENT LLC
$728.5M3,894,189 sh
PeakShares LLC
$515.0M2,753 sh
STATE STREET CORP
$514.7M2,751,290 sh
GLENVIEW CAPITAL MANAGEMENT, LLC
$418.2M2,235,666 sh
GEODE CAPITAL MANAGEMENT, LLC
$352.7M1,884,982 sh

Fund	Value	Shares
BlackRock, Inc.	$1.6B	8,743,005
PRICE T ROWE ASSOCIATES INC /MD/	$1.5B	7,957,449
Boston Partners	$829.1M	4,433,360
VANGUARD PORTFOLIO MANAGEMENT LLC	$792.9M	4,238,108
FMR LLC	$747.3M	3,994,545
VANGUARD CAPITAL MANAGEMENT LLC	$728.5M	3,894,189
PeakShares LLC	$515.0M	2,753
STATE STREET CORP	$514.7M	2,751,290
GLENVIEW CAPITAL MANAGEMENT, LLC	$418.2M	2,235,666
GEODE CAPITAL MANAGEMENT, LLC	$352.7M	1,884,982

Companies Similar to THC

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

BMY

BRISTOL MYERS SQUIBB CO

AI score

Similar quality profile · 17 shared holders

LSV ASSET MANAGEMENT BI Asset Management Fondsmaeglerselskab A/S Swedbank AB

UHS

UNIVERSAL HEALTH SERVICES INC

AI score

Similar quality profile · 27 shared holders

LSV ASSET MANAGEMENT Khrom Capital Management LLC MOORE CAPITAL MANAGEMENT, LP

DVA

DAVITA INC.

AI score

Similar quality profile · 15 shared holders

LSV ASSET MANAGEMENT WEDGE CAPITAL MANAGEMENT L L P/NC BI Asset Management Fondsmaeglerselskab A/S

ZTS

Zoetis Inc.

AI score

Similar quality profile · 14 shared holders

Swedbank AB BI Asset Management Fondsmaeglerselskab A/S Distillate Capital Partners LLC

EHC

Encompass Health Corp

AI score

Similar quality profile · 25 shared holders

Freestone Grove Partners LP Eversept Partners, LP Meridiem Capital Partners LP

HCA

HCA Healthcare, Inc.

AI score

Similar quality profile · 22 shared holders

T. Rowe Price Investment Management, Inc.Pentwater Capital Management LP LSV ASSET MANAGEMENT

IQV

IQVIA HOLDINGS INC.

AI score

Similar quality profile · 12 shared holders

Boston Partners Meridiem Capital Partners LP Freestone Grove Partners LP

CVS

CVS HEALTH Corp

AI score

Similar quality profile · 20 shared holders

GLENVIEW CAPITAL MANAGEMENT, LLC Boston Partners Clearbridge Investments, LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put THC on your watchlist

Track score changes the day TENET HEALTHCARE CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is THC a good stock to buy?

13F Pro's AI-powered analysis of TENET HEALTHCARE CORP (THC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for THC are available on the THC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. THC is classified as a large company.

Which hedge funds own THC?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling THC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of TENET HEALTHCARE CORP's investment landscape.